Strategic Analysis of the World Plant Molecular Farming Market

Table of Contents

1 STRATEGIC ANALYSIS OF THE WORLD PLANT MOLECULAR FARMING MARKET

Overview

World Industry Dynamics

• Influences on the Plant Molecular Farming Market
• Global Distribution of Transgenic Crops
• Key Market Engineering Measurements - World Biopharmaceuticals Market
• Total Market Revenue Forecasts - World Biopharmaceuticals Market

World Market Dynamics

• Key Challenges for the World Plant Molecular Farming Market
• Key Market Trends
• Current World Market Status
• Market Drivers
• Market Restraints
• Geographical World Industry Distribution
• Research Trends - Products in Development
• Worldwide Industry Participants

North American Market Dynamics

• North American Market Dynamics
• Current Industry Status - North America
• Forecast Assumptions
• Key Market Engineering Measurements
• Total Market Revenue Forecasts
• Market Analysis
• Product Timeline - North American Competitors
• Competitive Profiles

European Market Dynamics

• European Market Dynamics
• Current Industry Status - Europe
• Key Market Engineering Measurements
• Total Market Revenue Forecasts
• Market Analysis
• Product Timeline - European Competitors
• Competitive Profiles

Rest of World Market Dynamics

• Rest of World Market Dynamics
• Key Participants: Rest of World

Strategic Analysis & Reccomendations

• Strategic Analysis & Recommendations
• Key Challenges and Strategic Proposals
• Strategic Anticipation
• Market Maturation Process
• Market Penetration Strategy
• Competitive Framework
• Potential Threats
• Meeting the Challenge

Frost & Sullivan Awards

• Frost & Sullivan Awards Description
• Growth Strategy Leadership Award
• Technology Leadership Award
• Entrepreneurial Company Award
• Market Leadership Award
• Product Differentiation Innovation Award

Decision Support Databases

• Number of Biotechnology Companies - Western Europe and North America (1999-2006)
• Number of Biotechnology European Patents Filed (1996 - 2000)
• Governmental R&D Investment in Biotechnology (1996-2000)
• Pharmaceutical R&D Expenditure 1999 - 2006

Frost & Sullivan

• Healthcare Team
• Our Capabilities